Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/45966
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeron, S.en
dc.contributor.authorCox, K.en
dc.contributor.authorGrinton, B.en
dc.contributor.authorZuberi, S.en
dc.contributor.authorKivity, S.en
dc.contributor.authorAfawi, Z.en
dc.contributor.authorStraussberg, R.en
dc.contributor.authorBerkovic, S.en
dc.contributor.authorScheffer, I.en
dc.contributor.authorMulley, J.en
dc.date.issued2007en
dc.identifier.citationJournal of Medical Genetics, 2007; 44(12):791-796en
dc.identifier.issn0022-2593en
dc.identifier.issn1468-6244en
dc.identifier.urihttp://hdl.handle.net/2440/45966-
dc.descriptionCopyright © 2007 by the BMJ Publishing Group Ltd.en
dc.description.abstractBackground: Benign familial neonatal seizures are most often caused by mutations in the voltage-gated potassium channel subunit gene KCNQ2. More than 60 mutations have been described in BFNS families, approximately half of which lead to protein truncation. The hypothesis of this study was that deletion or duplication of 1 exons of KCNQ2 could cause BFNS in cases without coding or splicing mutations. Methods: Multiplex ligation-dependent probe amplification (MLPA) was used to test a group of 21 unrelated patients with clinical features consistent with either BFNS, benign familial neonatal–infantile seizures or sporadic neonatal seizures, for exonic deletions and duplications. Results: Three deletions and one duplication mutation were identified in four familial cases and cascade testing of their available family members showed that the mutations segregated with the phenotype in each family. The junction fragment for one of the deletions was amplified by PCR and sequenced to characterise the breakpoint and verify that a deletion had occurred. Conclusions: Submicroscopic deletions or duplications of KCNQ2 are seen in a significant proportion of BFNS families: four of nine (44%) cases previously testing negative for coding or splice site mutation by sequencing KCNQ2 and KCNQ3. MLPA is an efficient second-tier testing strategy for KCNQ2 to identify pathogenic intragenic mutations not detectable by conventional DNA sequencing methods.en
dc.description.statementofresponsibilityS E Heron, K Cox, B E Grinton, S M Zuberi, S Kivity, Z Afawi, R Straussberg, S F Berkovic, I E Scheffer and J C Mulleyen
dc.language.isoenen
dc.publisherBritish Med Journal Publ Groupen
dc.subjectneonatal seizures; deletion; duplication; epilepsy; potassium channel; MLPAen
dc.titleDeletions or duplications in KCNQ2 can cause benign familial neonatal seizuresen
dc.typeJournal articleen
dc.identifier.rmid0020073696en
dc.identifier.doi10.1136/jmg.2007.051938en
dc.identifier.pubid46876-
pubs.library.collectionMolecular and Biomedical Science publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidHeron, S. [0000-0001-8759-6748]en
Appears in Collections:Molecular and Biomedical Science publications

Files in This Item:
File Description SizeFormat 
hdl_45966.pdf337.81 kBPublisher's PDF View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.